CD3-directed Antibody
- Name
- CD3-directed Antibody
- Accession Number
- DBCAT005908
- Description
Not Available
- Drugs
Drug Drug Description Teplizumab A CD3-directed monoclonal antibody indicated to delay the onset of Stage 3 type 1 diabetes in patients with Stage 2 type 1 diabetes. - Drugs & Drug Targets
Drug Target Type Teplizumab T-cell surface glycoprotein CD3 epsilon chain target